Galectin Therapeutics Inc
GALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133416
In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Galectin Therapeutics Inc as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- +4 vs. Q4 2025
- Shares held
- 13.9M
- +4.60M (+49.2%) vs. Q4 2025
- Total value
- $38.8M
- +$133.3K (+0.3%) vs. Q4 2025
- New holders
- 19
- 31 more added
- Sold out
- 15
- 23 more reduced
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GALT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 98 | $72.2M |
| Q1 2026 | 99 | $38.8M |
| Q4 2025 | 98 | $48.1M |
| Q3 2025 | 84 | $43.9M |
| Q2 2025 | 86 | $22.2M |
| Q1 2025 | 93 | $12.2M |
| Q4 2024 | 94 | $13.0M |
| Q3 2024 | 79 | $26.8M |
| Q2 2024 | 73 | $21.6M |
| Q1 2024 | 59 | $18.2M |
| Q4 2023 | 66 | $12.0M |
| Q3 2023 | 60 | $17.4M |
| Q2 2023 | 60 | $10.5M |
| Q1 2023 | 60 | $15.0M |
| Q4 2022 | 61 | $8.04M |
| Q3 2022 | 59 | $11.3M |
| Q2 2022 | 60 | $9.25M |
| Q1 2022 | 60 | $12.0M |
| Q4 2021 | 55 | $15.2M |
| Q3 2021 | 70 | $28.2M |
| Q2 2021 | 75 | $25.3M |
| Q1 2021 | 75 | $22.7M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Galectin Therapeutics Inc; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Traynor Capital Management, Inc. | 0 | $0 | 0.00% | −101,600−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −82,478−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −51,936−100.0% | Sold out |
| Lido Advisors, LLC | 0 | $0 | 0.00% | −36,327−100.0% | Sold out |
| Tulsa Wealth Advisors, INC | 0 | $0 | 0.00% | −23,394−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −21,709−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −18,900−100.0% | Sold out |
| Mangrove Partners | 0 | $0 | 0.00% | −18,783−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −16,462−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −1,663−100.0% | Sold out |
| Quattro Advisors LLC | 0 | $0 | 0.00% | −634−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |